India Task Force

The India Task Force is driving nationally relevant progress in pulmonary arterial hypertension (PAH) care, research, and education across India. Working closely with PVRI’s global network, the group focuses on improving early diagnosis, strengthening clinical collaboration, and developing guidance that reflects the realities of the Indian healthcare system.

Recent activites

What we’ve been working on

The Task Force has made significant strides in building the foundations for consistent, high-quality PAH care nationwide:

• India’s first national PAH guidelines have been published — a landmark, India-wide guidance developed through PVRI collaboration
• A multicentre yoga trial in PAH has been initiated, exploring culturally relevant supportive therapies
• Digital stethoscope screening initiatives are being implemented to support earlier detection of PAH
• Hosted the PVRI India biennial Conference (February–March 2026), a two-day national meeting focused on advancing clinical practice, collaboration, and research in PH across India

What’s next

Momentum is building, with a strong focus on turning guidance into action:

• Nationwide dissemination of the Indian PAH guidelines
• Expanded participation in multicentre registries and pragmatic studies to strengthen real-world evidence from India

Publications

Bobhate, P., Awasthy, N., Babu, A.S., Giri, S., Gopalakrishnan, A. et al. (2026) ‘Challenges and Strategies in Managing Pulmonary Arterial Hypertension Within the Indian Healthcare System: A Consensus Statement From the Pulmonary Vascular Research Institute India Taskforce’. Pulmonary Circulation, 16 (2), e70311